// App-Quantinova.ai

: A Fully Human Anti-BMP6 Antibody Reduces the Need for Erythropoietin Stimulating Agent in Two Rodent Anemia of Chronic Disease Models

Researchers

Presenter

  • Verena Petzer

Principal Investigators

  • Piotr Tymoszuk

  • Matthew Wake

  • Luke Bayliss

  • Jonathan Papworth

  • Joana Carvalho

  • Cecilia Deantonio

  • Malte Ferdinand Asshoff

  • Markus Seifert

  • Sylvia Berger

  • Dominik Wolf

  • Gnter Weiss

  • Volker Germaschewski

  • Igor Theurl

Medical Centers

  • Medical University Innsbruck, Innsbruck, Austria

  • Kymab, Cambridge, United Kingdom.

  • Medical University of Innsbruck, Christian Doppler Laboratory for Iron Metabolism and Anemia Research, Innsbruck, Austria

  • Division of Hematology and Oncology, Innsbruck Medical University, Innsbruck, Austria

Locations

  • Austria

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Endocrine/metabolic Diseases (ME)

  • Autoimmune (AI)

  • Genetic Disorder

  • Blood/haematological Diseases

Disease

  • Chronic kidney disease

  • Hemochromatosis

  • Inflammatory Arthritis

  • Anemia

Biomarkers

  • Epithelial Cell Adhesion Molecule

  • Mean corpuscular volume

  • TIMP Metallopeptidase Inhibitor 1

Drug/Treatment

  • Sodium ferric gluconate complex

  • Erythropoietin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved